Jaclyn Tamaroff, MD, MSCI
Jaclyn Tamaroff, MD, MSCI
M.D.
Rutgers New Jersey Medical School, Newark, NJ, 2015
Residency
Pediatric Residency - Johns Hopkins University, Baltimore, MD
Fellowship
Pediatric Endocrinology - Children's Hospital of Philadelphia, Philadelphia, PA
M.S.C.I.
Vanderbilt University School of Medicine, Nashville, TN
Clinical Interests
General Endocrinology; Diabetes; Duchenne Muscular Dystrophy
Research Information
Dr. Tamaroff’s research program focuses on the use of wearable technology and the intersection between glycemia, insulin sensitivity, and cardiac disease. She has evaluated the use of continuous glucose monitors and the relationship between dysglycemia and cardiomyopathy in individuals with Friedreich’s Ataxia. She is currently investigating similar questions in individuals with Duchenne Muscular Dystrophy (DMD). Additionally, in individuals with DMD or pseudohypoparathyroidism, she is assessing the utility of remote monitoring during research studies to assess glycemia, activity, heart rate, and sleep.
Dr. Tamaroff complete a Master of Science in Clinical Investigation (MSCI) at Vanderbilt University School of Medicine. In 2023, she was named a Vanderbilt Scholar in Diabetes through the Vanderbilt Diabetes Research and Training Center and received the Turner Hazinski Award through the Department of Pediatrics. She is a 2024-2026 Katherine Dodd Faculty Scholar in the Department of Pediatrics. Dr. Tamaroff has received external grant funding from the National Institutes of Health, the Friedreich’s Ataxia Research Alliance, FightDMD, and the American Heart Association.